๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Accord Healthcare S.L.U. โ€” Licensed Medicines

177 medicines held by Accord Healthcare S.L.U. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 177 products held by Accord Healthcare S.L.U.
MedicineActive substanceLicence holderStatus
Temozolomide Accord 100 mg hard capsules
EU/1/10/615/009-010
Temozolomide Accord Healthcare S.L.U. โ€”
Temozolomide Accord 140 mg hard capsules
EU/1/10/615/013-014
Temozolomide Accord Healthcare S.L.U. โ€”
Temozolomide Accord 180 mg hard capsules
EU/1/10/615/017-018
Temozolomide Accord Healthcare S.L.U. โ€”
Temozolomide Accord 20 mg hard capsules
EU/1/10/615/005-006
Temozolomide Accord Healthcare S.L.U. โ€”
Temozolomide Accord 250 mg hard capsules
EU/1/10/615/021-022
Temozolomide Accord Healthcare S.L.U. โ€”
Temozolomide Accord 5 mg hard capsules
EU/1/10/615/001-002
Temozolomide Accord Healthcare S.L.U. โ€”
Teriflunomide Accord 14 mg film-coated tablets
EU/1/22/1693/001-004
Teriflunomide Accord Healthcare S.L.U. โ€”
Teriflunomide Accord 7 mg film-coated tablets
EU/1/22/1693/005-012
Teriflunomide Accord Healthcare S.L.U. โ€”
Tigecycline Accord 50 mg powder for solution for infusion
EU/1/19/1394/001-002
Tigecycline Accord Healthcare S.L.U. โ€”
Tolvaptan Accord 7.5 mg Tablet
EU/1/23/1719/001-004
Tolvaptan Accord Healthcare S.L.U. โ€”
Trabectedin Accord 0.25 mg powder for concentrate for solution for infusion
EU/1/24/1902/001
Trabectedin Accord Healthcare S.L.U. โ€”
Trabectedin Accord 1 mg powder for concentrate for solution for infusion
EU/1/24/1902/002
Trabectedin Accord Healthcare S.L.U. โ€”
Vildagliptin/Metformin hydrochloride Accord 50 mg/1000 mg Film-coated tablet
EU/1/21/1611/00-004
Vidagliptin, Metformin Hydrochloride Accord Healthcare S.L.U. โ€”
Vildagliptin/Metformin hydrochloride Accord 50 mg/850 mg Film-coated tablet
EU/1/21/1611/001-002
Vidagliptin, Metformin Hydrochloride Accord Healthcare S.L.U. โ€”
Voriconazole Accord 200 mg film-coated tablets
EU/1/13/835/010-018
Voriconazole Accord Healthcare S.L.U. โ€”
Voriconazole Accord 50 mg film-coated tablets
EU/1/13/835/001-009
Voriconazole Accord Healthcare S.L.U. โ€”
Zercepac 150 mg Powder for concentrate for solution for infusion
EU/1/20/1456/001
Trastuzumab Accord Healthcare S.L.U. โ€”
Zercepac 420 mg powder for concentrate for solution for infusion
EU/1/20/1456/003
Trastuzumab Accord Healthcare S.L.U. โ€”
Zercepac 60 mg powder for concentrate for solution for infusion
EU/1/20/1456/002
Trastuzumab Accord Healthcare S.L.U. โ€”
Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion
EU/1/13/834/001-003
Zoledronic acid monohydrate Accord Healthcare S.L.U. โ€”
ZOLSKETIL pegylated liposomal 2 mg/mL concentrate for dispersion for infusion
EU/1/22/1629/001-0004
Doxorubicin Hydrochloride, Liposomal Accord Healthcare S.L.U. โ€”
Zubsolv 0.7 mg/0.18 mg Sublingual tablet
EU/1/17/1233/001
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate Accord Healthcare S.L.U. โ€”
Zubsolv 1.4 mg/0.36 mg sublingual tablets
EU/1/17/1233/002
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate Accord Healthcare S.L.U. โ€”
Zubsolv 11.4 mg/2.9 mg Sublingual tablet
EU/1/17/1233/006
Naloxone hydrochloride dihydrate, Buprenorphine hydrochloride Accord Healthcare S.L.U. โ€”
Zubsolv 2.9 mg/0.71 mg Sublingual tablet
EU/1/17/1233/003
Naloxone hydrochloride dihydrate, Buprenorphine hydrochloride Accord Healthcare S.L.U. โ€”
Zubsolv 5.7 mg/1.4 mg Sublingual tablet
EU/1/17/1233/004
Naloxone hydrochloride dihydrate, Buprenorphine hydrochloride Accord Healthcare S.L.U. โ€”
Zubsolv 8.6 mg/2.1 mg Sublingual tablet
EU/1/17/1233/005
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate Accord Healthcare S.L.U. โ€”
โ† 1 2 3 4

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.